Song Youn Park

9PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 25, 2025
Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanoma.

Melissa M Yamada, Smitha Chandrasekhar, Ted A Gooley

|Aug 11, 2025
Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade.

Lisa Tachiki, Yasman Moshiri, Daniel S Hippe

|Mar 18, 2025
Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients.

Emily Gong, Lauren Zawacki, Xinyi Fan

|Jul 25, 2024
Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy.

Tomoko Akaike, Austin J Jabbour, Peter H Goff

|Jul 25, 2024
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.

Tomoko Akaike, Manisha Thakuria, Ann W Silk

|Jul 13, 2024
Lack of Clinically Significant Relationships of Age or Body Mass Index with Merkel Cell Carcinoma Immunotherapy Outcomes.

Rian Alam, Xinyi Fan, Daniel S Hippe

Pageof 2

Frequent Collaborators

8 joint publications

Paul T Nghiem

5 joint publications

Tomoko Akaike

4 joint publications

Shailender Bhatia

2 joint publications

Lisa C Zaba